KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,815,000 | -25.7% | 500,000 | -30.6% | 1.57% | +1.0% |
| Q2 2023 | $6,480,000 | -10.7% | 720,000 | -22.0% | 1.55% | -28.7% |
| Q1 2023 | $7,256,352 | +16.3% | 923,200 | 0.0% | 2.17% | +0.1% |
| Q4 2022 | $6,240,832 | -30.1% | 923,200 | +96.3% | 2.17% | +86.1% |
| Q4 2020 | $8,929,000 | +52.3% | 470,203 | 0.0% | 1.17% | +1.7% |
| Q3 2020 | $5,863,000 | +5.0% | 470,203 | +1.9% | 1.15% | +1.7% |
| Q2 2020 | $5,584,000 | +224.5% | 461,500 | +105.1% | 1.13% | +147.4% |
| Q1 2020 | $1,721,000 | – | 225,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |